Contrasting Assembly Biosciences (NASDAQ:ASMB) and Affymax (NASDAQ:AFFY) - Trent Times
Posted on Wednesday December 04, 2019

Contrasting Assembly Biosciences (NASDAQ:ASMB) and Affymax (NASDAQ:AFFY)  Trent Times

Is AFFYMAX INC (OTCMKTS:AFFY)'s Fuel Running Low? Reports Show More Sellers - The Lamp News
Posted on Saturday November 30, 2019

Is AFFYMAX INC (OTCMKTS:AFFY)'s Fuel Running Low? Reports Show More Sellers  The Lamp News

Assembly Biosciences (NASDAQ:ASMB) vs. Affymax (NASDAQ:AFFY) Head-To-Head Survey - Riverton Roll
Posted on Friday November 29, 2019

Assembly Biosciences (NASDAQ:ASMB) vs. Affymax (NASDAQ:AFFY) Head-To-Head Survey  Riverton Roll

RubrYc Therapeutics Announces formation of its Scientific Advisory Board - Maryville Daily Times
Posted on Wednesday December 04, 2019

RubrYc Therapeutics Announces formation of its Scientific Advisory Board  Maryville Daily Times

Head-To-Head Review: Affymax (OTCMKTS:AFFY) & Assembly Biosciences (OTCMKTS:ASMB) - TechNewsObserver
Posted on Thursday November 21, 2019

Head-To-Head Review: Affymax (OTCMKTS:AFFY) & Assembly Biosciences (OTCMKTS:ASMB)  TechNewsObserver

Affymax, once a promising biotech, is dissolving - FiercePharma
Posted on Tuesday June 24, 2014

Affymax, once a promising biotech, is dissolving  FiercePharma

Affymax Is Done. RIP. - TheStreet.com
Posted on Monday February 25, 2013

Affymax Is Done. RIP.  TheStreet.com

Affymax CEO steps down as restructuring firm steps in - San Francisco Business Times - San Francisco Business Times
Posted on Tuesday May 14, 2013

Affymax CEO steps down as restructuring firm steps in - San Francisco Business Times  San Francisco Business Times

NKMax America Announces Executive Advisory Board - PRNewswire
Posted on Monday November 11, 2019

NKMax America Announces Executive Advisory Board  PRNewswire

Affymax Cuts 230 Jobs, Mulls Bankruptcy, After Drug Withdrawal - Xconomy
Posted on Monday March 18, 2013

Affymax Cuts 230 Jobs, Mulls Bankruptcy, After Drug Withdrawal  Xconomy

Affymax Likely Worthless: Omontys Kills At Least 9x More People Than Epogen - Seeking Alpha
Posted on Wednesday August 28, 2013

Affymax Likely Worthless: Omontys Kills At Least 9x More People Than Epogen  Seeking Alpha

Affymax Lives to Fight Another Day, In Bid to Challenge Amgen's Monopoly - Xconomy
Posted on Monday August 09, 2010

Affymax Lives to Fight Another Day, In Bid to Challenge Amgen's Monopoly  Xconomy

Affymax Hires New CEO, Former Genentecher, to Complete FDA Push With Anemia Drug - Xconomy
Posted on Thursday January 06, 2011

Affymax Hires New CEO, Former Genentecher, to Complete FDA Push With Anemia Drug  Xconomy

Equillium Announces Leadership Updates Nasdaq:EQ - GlobeNewswire
Posted on Tuesday November 12, 2019

Equillium Announces Leadership Updates Nasdaq:EQ  GlobeNewswire

Spero Announces Appointment of Cynthia Smith to its Board of Directors - GlobeNewswire
Posted on Tuesday March 19, 2019

Spero Announces Appointment of Cynthia Smith to its Board of Directors  GlobeNewswire